U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07728487) titled 'Study of AT-587 in Healthy Subjects' on July 22.
Brief Summary: This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects
Study Start Date: July 13
Study Type: INTERVENTIONAL
Condition:
Hepatitis E
Intervention:
DRUG: AT-587
Parallel Assignment
OTHER: Placebo
Parallel Assignment
Recruitment Status: RECRUITING
Sponsor: Atea Pharmaceuticals, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....